Tauriga Sciences Inc. (TAUG) 0.0367 $TAUG
Tauriga Sciences, Inc. Responds to Negligent and Misleading Article Published July 16, 2014 by Hotstocked
GlobeNewswire - Thu Jul 17, 9:25AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"
, a diversified life sciences company, is responding to a negligent article which disseminated materially false information about the Company. This article titled "Tauriga Sciences Inc. has Turbulent Start to the Week," by Georgi Kamburov was published on July 16, 2014 by Hotstocked. This article was brought to the Company's attention by several shareholders, and the misinformation was so egregious that management believes a public rebuttal is necessary.
Tauriga Sciences enters into license agreement with Targeted Medical Pharma for launch of new cannabis complements product line
M2 - Thu Jul 17, 8:15AM CDT
Life sciences company Tauriga Sciences (Other OTC:TAUG) disclosed on Wednesday the launch of a non-exclusive licensing agreement under its "Cannabis Complements" product line.
Tauriga Sciences Inc. Signs License Agreement With Targeted Medical Pharma Inc.
GlobeNewswire - Wed Jul 16, 2:31PM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or the "Company", a diversified life sciences company, announced today it has signed a non-exclusive licensing agreement with Targeted Medical Pharma Inc. (OTCQB:TRGM) to reformulate and rebrand Targeted Medical's medical food formulations into dietary supplements as part of Tauriga's "Cannabis Complements" product line. Tauriga's new Cannabis Complements product line will be formally launched later in the summer and consists of dietary supplements and other natural wellness products that do not contain cannabis oil and that will attempt to address cannabis-related effects, such as anxiety, memory and cognitive functions, and appetite control. The products to be offered under the "Cannabis Complements" line will contain "GRAS" ingredients, the U.S. Food and Drug Administration's designation for ingredients that are "Generally Recognized as Safe".
Tauriga Sciences Inc. Completes Acquisition of Honeywood LLC, a California-Based Developer of Medicinal Cannabis Products, Including Doc Green's Cream
GlobeNewswire - Mon Jul 14, 4:21AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company", a diversified life sciences company, is pleased to announce that it has successfully completed its acquisition of California-based medicinal cannabis firm Honeywood LLC ("Honeywood", the formulator for Doc Green's topical cannabis cream and for other products. Under terms of the completed acquisition agreement, Honeywood will operate as a wholly owned subsidiary of Tauriga Sciences Inc., with all future revenues and profits (losses) to be reflected on Tauriga's pro forma financial statements. The final acquisition terms result in stakeholders of Honeywood receiving 15.5% of Tauriga Sciences non-diluted shares of common stock outstanding immediately prior to closing. Honeywood's principals have the opportunity to collectively earn up to an additional aggregate equal to 10% of Tauriga's common stock outstanding (utilizing the same initial Closing Date) upon achieving the following gross revenue based milestones: upon the generation and receipt of $2,000,000 USD of gross revenues derived strictly from the sale and licensing of Honeywood's products, the three Honeywood principals shall each be issued either restricted stock or stock options equal to 1.6666% shares of Common Stock of Tauriga; upon the generation and receipt of an additional $2,000,000 USD ($4,000,000 USD total gross revenues by Honeywood), its three principals shall each be issued an additional 1.6666% shares of Common Stock of Tauriga (each such additional issuance to be set off the outstanding shares immediately prior to the Closing Date).
Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Tauriga Sciences Inc. Wholly Owned Subsidiary Pilus Energy LLC Featured in CNBC Special "States Partner to Spur Innovation in New Industries"
GlobeNewswire - Wed Jun 25, 11:54AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company", a diversified life sciences company with a proprietary microbial fuel cell technology, today announced that its wholly owned subsidiary Pilus Energy LLC ("Pilus Energy" has been featured in a CNBC Special by Tom Cunneff, Titled: "States Partner to Spur Innovation in New Industries." The article discusses President Obama's $33 million Jobs and Innovation Accelerator Challenge as well as the public-private partnership between the states of Indiana, Kentucky and Ohio with the goal of bringing a focus and cohesiveness to all the different water entities in this H2O-rich area.
Tauriga Sciences Inc. and Honeywood LLC Successfully Amend Merger Agreement; Closing of Acquisition Remains on Track for July 10, 2014
GlobeNewswire - Mon Jun 23, 3:40AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company", a diversified life sciences company with a proprietary microbial fuel cell technology, is pleased to announce that its acquisition of Honeywood LLC ("Honeywood", and Doc Green's product lines) will be completed under terms that are significantly less dilutive to Tauriga shareholders than previously announced, as a result of the successful amendment to the Agreement and Plan of Merger, dated March 10, 2014 ("Merger Agreement". The acquisition is on track to be completed by July 10, 2014, the Closing date originally set forth in the Merger Agreement. As part of Tauriga's customary and continued due diligence of Honeywood LLC, including financials and analysis of the potential of Honeywood's new product lines, the parties have agreed to reduce the Honeywood consideration from 32% of Tauriga's fully-diluted capitalization to 18% of Tauriga's non-diluted shares of common stock outstanding at the time of closing. Tauriga has also agreed to provide an opportunity for Honeywood's principals to collectively earn up to an additional aggregate equal to 10% of Tauriga's common stock outstanding (utilizing the same initial Closing Date) upon achieving certain gross revenue based milestones. These revenue based milestones can be summarized as follows: upon the generation and receipt of $2.0MM of gross revenues derived strictly from the sale of Doc Green's and Honeywood's products, the three Honeywood principals shall each be issued either restricted stock or stock options equal to an additional 1.6666% shares of Common Stock of Tauriga. Upon the generation and receipt of an additional $2.0MM ($4.0 MM total gross revenues by Honeywood), its three principals shall each be issued an additional 1.6666% shares of Common Stock of Tauriga (each such additional issuance to be set off the outstanding shares at the initial Closing Date).
Advanced Cannabis Solutions, Tauriga Sciences and MassRoots to Present at the First Annual WeedStock Conference, Presented by Marketfy
ACCESSWIRE - Tue Jun 10, 3:49PM CDT
Southfield, MI / ACCESSWIRE / June 10, 2014 / WeedStock Conference, the premier cannabis investor conference, presented by Marketfy, is set to feature a robust line up of foremost experts in the Cannabis industry. Marketfy is proud to announce the inclusion of three additional industry leading companies at the almost-sold out conference.
Abattis to Speak at First Annual WeedStock Conference
ACCESSWIRE - Fri Jun 06, 1:07PM CDT
Vancouver, BC / ACCESSWIRE / June 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on North American medicinal markets, today announced that they will be presenting at the WeedStock conference presented by Marketfy. The conference will feature a robust lineup of the cannabis industry's foremost experts. Despite recent challenges facing the industry and its investors, widespread support of legalization across the country suggests that the cannabis industry is a viable long-term industry for investors.
Top Cannabis Experts To Speak at the First Annual WeedStock Conference, Presented by Marketfy
ACCESSWIRE - Tue Jun 03, 1:12PM CDT
Southfield, MI / ACCESSWIRE / June 3, 2014 / The industry-changing WeedStock conference, presented by Marketfy, is set to feature a robust lineup of foremost experts in the Cannabis industry. Despite recent challenges facing the industry and its investors, record high support of legalization across the country strongly indicates that the cannabis industry is a long-term investment.
A Diversified Bet on the Marijuana Sector
ACCESSWIRE - Thu May 29, 8:57AM CDT
WHITEFISH, MT / May 29, 2014 / The cannabis industry is a highly fragmented space right now, with companies like GW Pharmaceuticals plc (NASDAQ: GWPH) studying CBD's clinical potential, companies like Tauriga Sciences, Inc. (OTC: TAUG) exploring currently-legal topical medicinal products, companies like GreenGro Technologies Inc. (OTC: GRNH) focused on ancillary markets, and companies like Tweed Inc. (TWD:TSV) selling medical marijuana under Canada's new Marihuana for Medical Purposes Regulations ("MMPR".
Tauriga Sciences Inc. Enters First Distribution Agreement For Natural Medicine Products
ACCESSWIRE - Thu May 29, 7:37AM CDT
LOS ANGELES / ACCESSWIRE / May 29, 2014 / Tauriga Sciences Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company", a diversified life sciences company with a proprietary microbial fuel cell technology and a pending acquisition in the medicinal cannabis space, has entered into its first retail distribution agreement for its new line of natural medicine products. Tauriga's natural medicine product line is expected to launch this summer and will include non-cannabis containing candies, gums and supplements with proprietary formulations designed to address unwanted cannabis-related effects such as increased appetite, anxiety, and reduction in memory and cognitive function. The Company's first retail distribution agreement for these products is with SpeedWeed, a leading medical marijuana delivery service serving areas of Southern California in strict accordance with California regulations and health and safety codes.
Tauriga Sciences, Inc. to Present at the Third Annual Marcum MicroCap Conference
Thomson Reuters ONE - Tue May 27, 7:33AM CDT
Tauriga Sciences, Inc. to Present at the Third Annual Marcum MicroCap Conference
Cannabis Sector Acquisitions Fuel Recent Expansion in the Legal Medical & Recreational Marijuana Industry - Company Signs LOI For Asset Purchase of L.A. Dispensary
PR Newswire - Thu May 22, 7:50AM CDT
Cannabis Sector continues expansion with new site developments, acquisitions and new product announcements as the marijuana industry sees continual growth: OSL Holdings (OTC: OSLH), Creative Edge Nutrition, Inc. (OTC: FITX), Hemp, Inc. (OTC: HEMP), Tranzbyte Corporation (OTC: ERBB), Tauriga Sciences, Inc. (OTC: TAUG) and Cannabis Science, Inc. (OTC: CBIS)
Tauriga Sciences Inc. Fully Repays and Retires the Convertible Note Held by Group 10 Holdings LLC for Principal Amount of $157,500 USD
GlobeNewswire - Mon Mar 31, 10:41AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company", a diversified life sciences company with key assets that include active license agreements, topical medicinal cannabis lotions, and a proprietary microbial fuel cell technology, today announced that it has fully repaid a convertible note ("the note" held by Group 10 Holdings, LLC ("Group 10 Holdings" for the principal amount of $157,500 USD. On September 30, 2013, Tauriga borrowed $157,500 USD from Group 10 while the Company was negotiating with Bacterial Robotics LLC ("Bacterial Robotics" to acquire synthetic biology pioneer Pilus Energy LLC ("Pilus Energy". This capital infusion was crucial at that time, to provide the Company with the resources to execute the definitive merger agreement with Pilus Energy in late November 2013. The signing of that definitive agreement and the subsequent completion of the Pilus Energy acquisition on January 28, 2014 were unquestionably the catalysts that laid the foundation for future success. Including accrued interest and contractual buyout premiums, the note was fully repaid and retired for a cash payment of $225,487.36 USD. Therefore, there will be absolutely no share conversions owed to Group 10 Holdings in conjunction with this note and the corresponding debt has been removed from the Company's balance sheet.
Tauriga Sciences Inc. Completes $800,000 USD Equity Private Placement Priced at 6 Cents per Share
GlobeNewswire - Mon Mar 31, 5:22AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company", a diversified life sciences company with key assets that include active license agreements, interests in a topical medicinal cannabis company, and a proprietary microbial fuel cell technology, has today announced the completion of a $800,000 USD equity private placement at a price of 6 cents per share ("$0.06" to various accredited investors. There were no warrants or registration rights offered in conjunction with this private placement financing. The shares issued pursuant to this private placement are "restricted securities" as defined by Rule 144 of the Securities Act of 1933, as amended.
CBS Outdoor Americas Climbs on First Day of Trading; FDA Advisory Panel Recommends Approval of Exact Sciences Corporation's Cologuard
ACCESSWIRE - Sun Mar 30, 11:16PM CDT
CBS Outdoor Americas Inc. (NYSE: CBSO) - For an in-depth report on CBS Outdoor Americas Inc. follow: www.BullTrends.com/stockquote/CBSO
Tauriga Sciences Inc. Launches $1,700,000 USD Commercial Pilot Test With the EPA and the Metropolitan Sewer District of Greater Cincinnati
GlobeNewswire - Wed Mar 26, 2:02PM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company", a diversified life sciences company with key assets that include license agreements and a proprietary technology platform in the nanorobotics space, has today announced that its wholly owned subsidiary Pilus Energy LLC ("Pilus Energy" has commenced a five-phase, $1,700,000 USD commercial pilot test ("commercial pilot" with the Environmental Protection Agency ("EPA", utilizing Chicago Bridge & Iron Co. (NYSE:CBI) ("CB&I" Federal Services serving as the third-party-contractor through the EPA's Test and Evaluation ("T&E" facility. This five phase commercial pilot will include significant testing of the Pilus Energy Electrogenic Bioreactor ("EBR" synthetic biology platform for generating value from wastewater. This commercial pilot is of great importance to the Company, because it represents the scale up from the benchtop (laboratory) scale to commercial (industrial) scale. The Metropolitan Sewer District of Greater Cincinnati ("MSDGR", which is co-located with EPA's T&E facility, will host the commercial scale EBR prototype at its main treatment plant in Cincinnati.
Tauriga Sciences Inc. Fully Retires the Secured Convertible Promissory Note Held by Typenex Co-Investment, LLC for Original Principal Amount of $555,000 USD
GlobeNewswire - Mon Mar 24, 2:05AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company", a diversified life sciences company with key assets that include license agreements, topical medicinal cannabis lotions, and a proprietary technology platform in the nanorobotics space, today announced that it has fully retired a convertible note held by Typenex Co-Investment, LLC ("Typenex" for the principal amount of $555,000 USD. On June 24, 2013, the Company entered into a Securities Purchase Agreement with Typenex, for the sale of an 8% convertible promissory note (the "Note" in the principal amount of $550,000 (which included Typenex's legal expenses in the amount of $7,500 and a $50,000 original issue discount). By retiring the Note, the Company has removed the corresponding debt from its balance sheet. Additionally the Company is working diligently to repay and retire the entirety of its remaining convertible debt and will update shareholders, once this important goal is accomplished.
Tauriga Sciences, Inc. Responds to Negligent and Misleading Article Published July 16, 2014 by Hotstocked
GlobeNewswire - Thu Jul 17, 9:25AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"
, a diversified life sciences company, is responding to a negligent article which disseminated materially false information about the Company. This article titled "Tauriga Sciences Inc. has Turbulent Start to the Week," by Georgi Kamburov was published on July 16, 2014 by Hotstocked. This article was brought to the Company's attention by several shareholders, and the misinformation was so egregious that management believes a public rebuttal is necessary. Tauriga Sciences enters into license agreement with Targeted Medical Pharma for launch of new cannabis complements product line
M2 - Thu Jul 17, 8:15AM CDT
Life sciences company Tauriga Sciences (Other OTC:TAUG) disclosed on Wednesday the launch of a non-exclusive licensing agreement under its "Cannabis Complements" product line.
Tauriga Sciences Inc. Signs License Agreement With Targeted Medical Pharma Inc.
GlobeNewswire - Wed Jul 16, 2:31PM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, announced today it has signed a non-exclusive licensing agreement with Targeted Medical Pharma Inc. (OTCQB:TRGM) to reformulate and rebrand Targeted Medical's medical food formulations into dietary supplements as part of Tauriga's "Cannabis Complements" product line. Tauriga's new Cannabis Complements product line will be formally launched later in the summer and consists of dietary supplements and other natural wellness products that do not contain cannabis oil and that will attempt to address cannabis-related effects, such as anxiety, memory and cognitive functions, and appetite control. The products to be offered under the "Cannabis Complements" line will contain "GRAS" ingredients, the U.S. Food and Drug Administration's designation for ingredients that are "Generally Recognized as Safe". Tauriga Sciences Inc. Completes Acquisition of Honeywood LLC, a California-Based Developer of Medicinal Cannabis Products, Including Doc Green's Cream
GlobeNewswire - Mon Jul 14, 4:21AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company, is pleased to announce that it has successfully completed its acquisition of California-based medicinal cannabis firm Honeywood LLC ("Honeywood", the formulator for Doc Green's topical cannabis cream and for other products. Under terms of the completed acquisition agreement, Honeywood will operate as a wholly owned subsidiary of Tauriga Sciences Inc., with all future revenues and profits (losses) to be reflected on Tauriga's pro forma financial statements. The final acquisition terms result in stakeholders of Honeywood receiving 15.5% of Tauriga Sciences non-diluted shares of common stock outstanding immediately prior to closing. Honeywood's principals have the opportunity to collectively earn up to an additional aggregate equal to 10% of Tauriga's common stock outstanding (utilizing the same initial Closing Date) upon achieving the following gross revenue based milestones: upon the generation and receipt of $2,000,000 USD of gross revenues derived strictly from the sale and licensing of Honeywood's products, the three Honeywood principals shall each be issued either restricted stock or stock options equal to 1.6666% shares of Common Stock of Tauriga; upon the generation and receipt of an additional $2,000,000 USD ($4,000,000 USD total gross revenues by Honeywood), its three principals shall each be issued an additional 1.6666% shares of Common Stock of Tauriga (each such additional issuance to be set off the outstanding shares immediately prior to the Closing Date). Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Tauriga Sciences Inc. Wholly Owned Subsidiary Pilus Energy LLC Featured in CNBC Special "States Partner to Spur Innovation in New Industries"
GlobeNewswire - Wed Jun 25, 11:54AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with a proprietary microbial fuel cell technology, today announced that its wholly owned subsidiary Pilus Energy LLC ("Pilus Energy" has been featured in a CNBC Special by Tom Cunneff, Titled: "States Partner to Spur Innovation in New Industries." The article discusses President Obama's $33 million Jobs and Innovation Accelerator Challenge as well as the public-private partnership between the states of Indiana, Kentucky and Ohio with the goal of bringing a focus and cohesiveness to all the different water entities in this H2O-rich area. Tauriga Sciences Inc. and Honeywood LLC Successfully Amend Merger Agreement; Closing of Acquisition Remains on Track for July 10, 2014
GlobeNewswire - Mon Jun 23, 3:40AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with a proprietary microbial fuel cell technology, is pleased to announce that its acquisition of Honeywood LLC ("Honeywood", and Doc Green's product lines) will be completed under terms that are significantly less dilutive to Tauriga shareholders than previously announced, as a result of the successful amendment to the Agreement and Plan of Merger, dated March 10, 2014 ("Merger Agreement". The acquisition is on track to be completed by July 10, 2014, the Closing date originally set forth in the Merger Agreement. As part of Tauriga's customary and continued due diligence of Honeywood LLC, including financials and analysis of the potential of Honeywood's new product lines, the parties have agreed to reduce the Honeywood consideration from 32% of Tauriga's fully-diluted capitalization to 18% of Tauriga's non-diluted shares of common stock outstanding at the time of closing. Tauriga has also agreed to provide an opportunity for Honeywood's principals to collectively earn up to an additional aggregate equal to 10% of Tauriga's common stock outstanding (utilizing the same initial Closing Date) upon achieving certain gross revenue based milestones. These revenue based milestones can be summarized as follows: upon the generation and receipt of $2.0MM of gross revenues derived strictly from the sale of Doc Green's and Honeywood's products, the three Honeywood principals shall each be issued either restricted stock or stock options equal to an additional 1.6666% shares of Common Stock of Tauriga. Upon the generation and receipt of an additional $2.0MM ($4.0 MM total gross revenues by Honeywood), its three principals shall each be issued an additional 1.6666% shares of Common Stock of Tauriga (each such additional issuance to be set off the outstanding shares at the initial Closing Date). Advanced Cannabis Solutions, Tauriga Sciences and MassRoots to Present at the First Annual WeedStock Conference, Presented by Marketfy
ACCESSWIRE - Tue Jun 10, 3:49PM CDT
Southfield, MI / ACCESSWIRE / June 10, 2014 / WeedStock Conference, the premier cannabis investor conference, presented by Marketfy, is set to feature a robust line up of foremost experts in the Cannabis industry. Marketfy is proud to announce the inclusion of three additional industry leading companies at the almost-sold out conference.
Abattis to Speak at First Annual WeedStock Conference
ACCESSWIRE - Fri Jun 06, 1:07PM CDT
Vancouver, BC / ACCESSWIRE / June 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on North American medicinal markets, today announced that they will be presenting at the WeedStock conference presented by Marketfy. The conference will feature a robust lineup of the cannabis industry's foremost experts. Despite recent challenges facing the industry and its investors, widespread support of legalization across the country suggests that the cannabis industry is a viable long-term industry for investors. Top Cannabis Experts To Speak at the First Annual WeedStock Conference, Presented by Marketfy
ACCESSWIRE - Tue Jun 03, 1:12PM CDT
Southfield, MI / ACCESSWIRE / June 3, 2014 / The industry-changing WeedStock conference, presented by Marketfy, is set to feature a robust lineup of foremost experts in the Cannabis industry. Despite recent challenges facing the industry and its investors, record high support of legalization across the country strongly indicates that the cannabis industry is a long-term investment.
A Diversified Bet on the Marijuana Sector
ACCESSWIRE - Thu May 29, 8:57AM CDT
WHITEFISH, MT / May 29, 2014 / The cannabis industry is a highly fragmented space right now, with companies like GW Pharmaceuticals plc (NASDAQ: GWPH) studying CBD's clinical potential, companies like Tauriga Sciences, Inc. (OTC: TAUG) exploring currently-legal topical medicinal products, companies like GreenGro Technologies Inc. (OTC: GRNH) focused on ancillary markets, and companies like Tweed Inc. (TWD:TSV) selling medical marijuana under Canada's new Marihuana for Medical Purposes Regulations ("MMPR"
. Tauriga Sciences Inc. Enters First Distribution Agreement For Natural Medicine Products
ACCESSWIRE - Thu May 29, 7:37AM CDT
LOS ANGELES / ACCESSWIRE / May 29, 2014 / Tauriga Sciences Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with a proprietary microbial fuel cell technology and a pending acquisition in the medicinal cannabis space, has entered into its first retail distribution agreement for its new line of natural medicine products. Tauriga's natural medicine product line is expected to launch this summer and will include non-cannabis containing candies, gums and supplements with proprietary formulations designed to address unwanted cannabis-related effects such as increased appetite, anxiety, and reduction in memory and cognitive function. The Company's first retail distribution agreement for these products is with SpeedWeed, a leading medical marijuana delivery service serving areas of Southern California in strict accordance with California regulations and health and safety codes. Tauriga Sciences, Inc. to Present at the Third Annual Marcum MicroCap Conference
Thomson Reuters ONE - Tue May 27, 7:33AM CDT
Tauriga Sciences, Inc. to Present at the Third Annual Marcum MicroCap Conference
Cannabis Sector Acquisitions Fuel Recent Expansion in the Legal Medical & Recreational Marijuana Industry - Company Signs LOI For Asset Purchase of L.A. Dispensary
PR Newswire - Thu May 22, 7:50AM CDT
Cannabis Sector continues expansion with new site developments, acquisitions and new product announcements as the marijuana industry sees continual growth: OSL Holdings (OTC: OSLH), Creative Edge Nutrition, Inc. (OTC: FITX), Hemp, Inc. (OTC: HEMP), Tranzbyte Corporation (OTC: ERBB), Tauriga Sciences, Inc. (OTC: TAUG) and Cannabis Science, Inc. (OTC: CBIS)
Tauriga Sciences Inc. Fully Repays and Retires the Convertible Note Held by Group 10 Holdings LLC for Principal Amount of $157,500 USD
GlobeNewswire - Mon Mar 31, 10:41AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with key assets that include active license agreements, topical medicinal cannabis lotions, and a proprietary microbial fuel cell technology, today announced that it has fully repaid a convertible note ("the note" held by Group 10 Holdings, LLC ("Group 10 Holdings" for the principal amount of $157,500 USD. On September 30, 2013, Tauriga borrowed $157,500 USD from Group 10 while the Company was negotiating with Bacterial Robotics LLC ("Bacterial Robotics" to acquire synthetic biology pioneer Pilus Energy LLC ("Pilus Energy". This capital infusion was crucial at that time, to provide the Company with the resources to execute the definitive merger agreement with Pilus Energy in late November 2013. The signing of that definitive agreement and the subsequent completion of the Pilus Energy acquisition on January 28, 2014 were unquestionably the catalysts that laid the foundation for future success. Including accrued interest and contractual buyout premiums, the note was fully repaid and retired for a cash payment of $225,487.36 USD. Therefore, there will be absolutely no share conversions owed to Group 10 Holdings in conjunction with this note and the corresponding debt has been removed from the Company's balance sheet. Tauriga Sciences Inc. Completes $800,000 USD Equity Private Placement Priced at 6 Cents per Share
GlobeNewswire - Mon Mar 31, 5:22AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with key assets that include active license agreements, interests in a topical medicinal cannabis company, and a proprietary microbial fuel cell technology, has today announced the completion of a $800,000 USD equity private placement at a price of 6 cents per share ("$0.06" to various accredited investors. There were no warrants or registration rights offered in conjunction with this private placement financing. The shares issued pursuant to this private placement are "restricted securities" as defined by Rule 144 of the Securities Act of 1933, as amended. CBS Outdoor Americas Climbs on First Day of Trading; FDA Advisory Panel Recommends Approval of Exact Sciences Corporation's Cologuard
ACCESSWIRE - Sun Mar 30, 11:16PM CDT
CBS Outdoor Americas Inc. (NYSE: CBSO) - For an in-depth report on CBS Outdoor Americas Inc. follow: www.BullTrends.com/stockquote/CBSO
Tauriga Sciences Inc. Launches $1,700,000 USD Commercial Pilot Test With the EPA and the Metropolitan Sewer District of Greater Cincinnati
GlobeNewswire - Wed Mar 26, 2:02PM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with key assets that include license agreements and a proprietary technology platform in the nanorobotics space, has today announced that its wholly owned subsidiary Pilus Energy LLC ("Pilus Energy" has commenced a five-phase, $1,700,000 USD commercial pilot test ("commercial pilot" with the Environmental Protection Agency ("EPA", utilizing Chicago Bridge & Iron Co. (NYSE:CBI) ("CB&I" Federal Services serving as the third-party-contractor through the EPA's Test and Evaluation ("T&E" facility. This five phase commercial pilot will include significant testing of the Pilus Energy Electrogenic Bioreactor ("EBR" synthetic biology platform for generating value from wastewater. This commercial pilot is of great importance to the Company, because it represents the scale up from the benchtop (laboratory) scale to commercial (industrial) scale. The Metropolitan Sewer District of Greater Cincinnati ("MSDGR", which is co-located with EPA's T&E facility, will host the commercial scale EBR prototype at its main treatment plant in Cincinnati. Tauriga Sciences Inc. Fully Retires the Secured Convertible Promissory Note Held by Typenex Co-Investment, LLC for Original Principal Amount of $555,000 USD
GlobeNewswire - Mon Mar 24, 2:05AM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with key assets that include license agreements, topical medicinal cannabis lotions, and a proprietary technology platform in the nanorobotics space, today announced that it has fully retired a convertible note held by Typenex Co-Investment, LLC ("Typenex" for the principal amount of $555,000 USD. On June 24, 2013, the Company entered into a Securities Purchase Agreement with Typenex, for the sale of an 8% convertible promissory note (the "Note" in the principal amount of $550,000 (which included Typenex's legal expenses in the amount of $7,500 and a $50,000 original issue discount). By retiring the Note, the Company has removed the corresponding debt from its balance sheet. Additionally the Company is working diligently to repay and retire the entirety of its remaining convertible debt and will update shareholders, once this important goal is accomplished. 
